Entera Bio Ltd. (ENTX) at a glance

Entera Bio Ltd. (ENTX) is a micro-cap Healthcare company. It trades at $1.99, with a 0% profit margin. It does not pay a dividend. Vestovix scores it 33/100 overall. Its strongest dimension is Value (50/100) and its weakest is Growth (10/100). It carries above-market volatility, so expect larger swings.

Price

$1.99

Market cap

$60.6M

P/E ratio

n/a

Dividend yield

None

Beta

1.49

52-week range

$0.91 to $3.22